Cognition and MRI Markers in MS Patients With Aubagio ® Treatment
Condition: Multiple Sclerosis, Relapsing-Remitting Interventions: Other: Clinical assessment; Other: Ecological evaluation; Other: Neuropsychological evaluation; Other: Psychological evaluation; Device: MRI Evaluation Sponsors: University Hospital, Bordeaux; Genzyme, a Sanofi Company Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials